Go Pro
→ Iran War TRUTH: What Two Congressmen Led Me To (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FG Nexus Inc stock logo
FGNX
FG Nexus
$8.10
-1.2%		$7.42
$4.18
▼
$37.55
$38.15M1.09107,108 shs87,529 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.93
+0.3%		$3.07
$2.34
▼
$11.89
$61.08M2.53466,448 shs114,194 shs
Tharimmune, Inc. stock logo
THAR
Tharimmune
$2.24
-8.6%		$2.12
$0.95
▼
$9.08
$84.52M1.431.48 million shs535,340 shs
Upexi, Inc. stock logo
UPXI
Upexi
$1.17
-0.4%		$0.95
$0.54
▼
$7.75
$95.65M-0.213.79 million shs980,348 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FG Nexus Inc stock logo
FGNX
FG Nexus
+1.49%+27.13%+8.75%+50.46%-75.41%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-1.75%+19.88%+20.25%+32.43%-61.19%
Tharimmune, Inc. stock logo
THAR
Tharimmune
+0.41%+19.80%+11.87%-8.07%-13.12%
Upexi, Inc. stock logo
UPXI
Upexi
-6.40%+11.43%+13.04%+53.95%-81.04%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FG Nexus Inc stock logo
FGNX
FG Nexus
$8.10
-1.2%		$7.42
$4.18
▼
$37.55
$38.15M1.09107,108 shs87,529 shs
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$3.93
+0.3%		$3.07
$2.34
▼
$11.89
$61.08M2.53466,448 shs114,194 shs
Tharimmune, Inc. stock logo
THAR
Tharimmune
$2.24
-8.6%		$2.12
$0.95
▼
$9.08
$84.52M1.431.48 million shs535,340 shs
Upexi, Inc. stock logo
UPXI
Upexi
$1.17
-0.4%		$0.95
$0.54
▼
$7.75
$95.65M-0.213.79 million shs980,348 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FG Nexus Inc stock logo
FGNX
FG Nexus
+1.49%+27.13%+8.75%+50.46%-75.41%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-1.75%+19.88%+20.25%+32.43%-61.19%
Tharimmune, Inc. stock logo
THAR
Tharimmune
+0.41%+19.80%+11.87%-8.07%-13.12%
Upexi, Inc. stock logo
UPXI
Upexi
-6.40%+11.43%+13.04%+53.95%-81.04%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FG Nexus Inc stock logo
FGNX
FG Nexus
2.40
Hold$35.00332.10% Upside
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
2.25
Hold$9.83149.94% Upside
Tharimmune, Inc. stock logo
THAR
Tharimmune
1.00
SellN/AN/A
Upexi, Inc. stock logo
UPXI
Upexi
2.00
Hold$5.00329.18% Upside

Current Analyst Ratings Breakdown

Latest FGNX, UPXI, THAR, and HYPD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2026
Upexi, Inc. stock logo
UPXI
Upexi
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$2.00
9/10/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$7.10 ➝ $11.20
9/10/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
9/10/2026
Upexi, Inc. stock logo
UPXI
Upexi
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$1.30 ➝ $2.00
9/8/2026
FG Nexus Inc stock logo
FGNX
FG Nexus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
9/8/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Chardan Capital logo
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$7.30 ➝ $8.45
9/4/2026
Upexi, Inc. stock logo
UPXI
Upexi
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/1/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
8/21/2026
FG Nexus Inc stock logo
FGNX
FG Nexus
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
8/18/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
8/13/2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$6.60 ➝ $7.10
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FG Nexus Inc stock logo
FGNX
FG Nexus
$2.41M15.83N/AN/A$15.32 per share0.53
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
$1.40M43.61N/AN/A$4.73 per share0.83
Tharimmune, Inc. stock logo
THAR
Tharimmune
N/AN/AN/AN/A$0.68 per shareN/A
Upexi, Inc. stock logo
UPXI
Upexi
$25M3.83N/AN/A($0.68) per share-1.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FG Nexus Inc stock logo
FGNX
FG Nexus
-$66.74M-$6.98N/AN/AN/A-4,888.86%-95.68%-75.45%N/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
-$45.31M-$6.53N/A3.97N/A416.56%-11.62%-9.96%N/A
Tharimmune, Inc. stock logo
THAR
Tharimmune
-$12.20M-$3.99N/AN/AN/AN/A-588.45%-264.41%N/A
Upexi, Inc. stock logo
UPXI
Upexi
-$246.07M-$4.06N/AN/AN/A-984.34%-157.49%-22.60%11/11/2026 (Estimated)

Latest FGNX, UPXI, THAR, and HYPD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/17/2026Q4 2026
Upexi, Inc. stock logo
UPXI
Upexi
-$0.11-$0.10+$0.01-$2.20$5.80 million$6.52 million
8/13/2026Q2 2026
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/A$0.92N/A$0.92N/A$0.36 million
8/12/2026Q2 2026
FG Nexus Inc stock logo
FGNX
FG Nexus
-$6.45-$3.07+$3.38-$3.07N/A$0.24 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
FG Nexus Inc stock logo
FGNX
FG Nexus
N/AN/AN/AN/AN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
N/AN/AN/AN/AN/A
Tharimmune, Inc. stock logo
THAR
Tharimmune
N/AN/AN/AN/AN/A
Upexi, Inc. stock logo
UPXI
Upexi
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FG Nexus Inc stock logo
FGNX
FG Nexus
N/A
6.80
6.80
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
0.06
2.34
2.34
Tharimmune, Inc. stock logo
THAR
Tharimmune
N/A
4.98
4.98
Upexi, Inc. stock logo
UPXI
Upexi
2.96
1.64
1.64

Institutional Ownership

CompanyInstitutional Ownership
FG Nexus Inc stock logo
FGNX
FG Nexus
3.13%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
25.84%
Tharimmune, Inc. stock logo
THAR
Tharimmune
1.16%
Upexi, Inc. stock logo
UPXI
Upexi
5.68%

Insider Ownership

CompanyInsider Ownership
FG Nexus Inc stock logo
FGNX
FG Nexus
4.10%
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
7.50%
Tharimmune, Inc. stock logo
THAR
Tharimmune
6.70%
Upexi, Inc. stock logo
UPXI
Upexi
9.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
FG Nexus Inc stock logo
FGNX
FG Nexus
154.71 million4.52 millionN/A
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
915.54 million14.37 millionNo Data
Tharimmune, Inc. stock logo
THAR
Tharimmune
237.73 million35.20 millionNot Optionable
Upexi, Inc. stock logo
UPXI
Upexi
5982.10 million74.71 millionOptionable

Recent News About These Companies

Upexi Earnings Call: High-Stakes Bet on Solana
September 22 at 8:31 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/upexi-earnings-call-high-stakes-bet-on-solana?utm_source=marketbeat.com&utm_medium=referral
UPEXI (NASDAQ: UPXI) Reports $25M Revenue, $246M Net Loss, Highlights Growth in Digital Asset Revenue
September 20, 2026  |  kalkinemedia.comK
Cantor Fitzgerald Reiterates "Overweight" Rating for Upexi (NASDAQ:UPXI)
September 20, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31033796
Upexi (NASDAQ:UPXI) Lowered to Sell Rating by Wall Street Zen
September 20, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31033538
Upexi (NASDAQ:UPXI) Stock Rating Lowered by Wall Street Zen
September 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-upexi-nasdaq-upxi-stock-rating-lowered-by-wall-street-zen-2026-09-20/
Analysts Offer Insights on Communication Services Companies: Upexi (UPXI) and AT&T (T)
September 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/UPXI/pressreleases/4693592/analysts-offer-insights-on-communication-services-companies-upexi-upxi-and-att-t/
Upexi expects staking revenue to more than cover ongoing cash expenses as it cuts headcount to 10 and refinances debt to 7.5%
September 18, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4644146-upexi-expects-staking-revenue-to-more-than-cover-ongoing-cash-expenses-as-it-cuts-headcount
Upexi (UPXI) Q4 2026 Earnings Call Transcript
September 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/upexi-upxi-q4-2026-earnings-155743880.html
Upexi Target of Unusually Large Options Trading (NASDAQ:UPXI)
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-upexi-target-of-unusually-large-options-trading-nasdaq-upxi-2026-09-18/
Upexi (NASDAQ:UPXI) Receives Overweight Rating from Cantor Fitzgerald
September 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-upexi-nasdaq-upxi-receives-overweight-rating-from-cantor-fitzgerald-2026-09-18/
Upexi Q4 Earnings Call Highlights
September 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transcript-upexi-q4-earnings-call-highlights-2026-09-17/
Upexi (UPXI) Stock Falls on Quarterly Earnings
September 17, 2026  |  quiverquant.comQ
Upexi Reports Fiscal 2026 Results, Digital Asset Revenue of $17.4 Million and 2.34 Million SOL Held at Year-End
September 17, 2026  |  quiverquant.comQ
Upexi Reports Financial Results for Fiscal Year Ended June 30, 2026
September 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/17/3364395/0/en/upexi-reports-financial-results-for-fiscal-year-ended-june-30-2026.html
Upexi (UPXI) to Post Quarterly Earnings on Thursday
September 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027614
Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET
September 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/15/3362019/0/en/upexi-to-host-fiscal-year-2026-earnings-call-on-thursday-september-17th-at-5-30-p-m-et.html
Upexi Amends BitGo Credit Facility
September 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/14/3361016/0/en/upexi-amends-bitgo-credit-facility.html
Wall Street Zen Upgrades Upexi (NASDAQ:UPXI) to "Hold"
September 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-wall-street-zen-upgrades-upexi-nasdaq-upxi-to-hold-2026-09-12/
Cantor Fitzgerald Boosts Upexi (NASDAQ:UPXI) Price Target to $2.00
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-cantor-fitzgerald-boosts-upexi-nasdaq-upxi-price-target-to-200-2026-09-10/
Upexi to Participate in FT Partners FinTech Conference 2026 on September 15th
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357612/0/en/upexi-to-participate-in-ft-partners-fintech-conference-2026-on-september-15th.html
Upexi (UPXI) Expected to Release Earnings on Wednesday
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/upcoming-upexi-upxi-expected-to-release-earnings-on-wednesday-2026-08-26/

New MarketBeat Followers Over Time

Media Sentiment Over Time

FG Nexus stock logo

FG Nexus NASDAQ:FGNX

$8.10 -0.10 (-1.22%)
As of 10:47 AM Eastern
This is a fair market value price provided by Massive. Learn more.

FG Financial Group, Inc. operates as a reinsurance and investment management holding company in the United States. The company offers specialty property and casualty reinsurance products and services. It also operates a special purpose acquisition company platform (SPAC) that provides various strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. The company was formerly known as 1347 Property Insurance Holdings, Inc. and changed its name to FG Financial Group, Inc. in December 2020. The company was incorporated in 2012 and is based in St. Petersburg, Florida.

Hyperion DeFi stock logo

Hyperion DeFi NASDAQ:HYPD

$3.93 +0.01 (+0.28%)
As of 10:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Tharimmune stock logo

Tharimmune NASDAQ:THAR

$2.24 -0.21 (-8.57%)
As of 09/23/2026

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic diseases. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH3215 and TH0059 that are product candidates used to treat various solid tumors; and TH1940, which targets programmed cell death protein 1 (PD-1). It has a research collaboration and product license agreement with Minotaur Therapeutics, Inc. for the development of proprietary targeted biologics; and Washington University in St. Louis for the rights to develop and commercialize technology related to multiple hybridomas and antibodies directed specifically towards human HER2. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was incorporated in 2017 and is headquartered in Bridgewater, New Jersey.

Upexi stock logo

Upexi NASDAQ:UPXI

$1.16 -0.01 (-0.43%)
As of 10:48 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas